Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

13.3%

2 terminated/withdrawn out of 15 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

20%

3 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

5(50.0%)

Phase 3

3(30.0%)

Phase 2

1(10.0%)

Phase 1

1(10.0%)

10Total

N/A(5)

Phase 3(3)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT07429344Recruiting

EASY Algorithm Trial (Elbow Trauma Assessment Using Sonography in Children and Youth) Diagnostic Accuracy and Safety of Point-of-care Ultrasound as a Screening Tool for Suspected Elbow Fractures in Children Aged 5 to 15 Years: a Multicenter Prospective Cohort Study

Role: collaborator

NCT04931368Phase 3Active Not Recruiting

OptiMATe: De-escalated Induction Treatment in Primary CNS Lymphoma

Role: lead

NCT06355050Not Yet Recruiting

Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer

Role: collaborator

NCT06830421Phase 3Recruiting

Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochemotherapy in Elderly PCNSL Patients

Role: collaborator

NCT05006092Not ApplicableCompleted

Surveillance Modified by Artificial Intelligence in Endoscopy (SMARTIE)